An epigenetic lesion could be responsible for acute T-cell leukemia

(IDIBELL-Bellvitge Biomedical Research Institute) Researchers from the Epigenetics and Cancer Biology Program (PEBC) led by Dr. Manel Esteller at IDIBELL have discovered how an epigenetic lesion can lead to T-cell acute lymphoblastic leukemia. The article, published in the journal Leukemia, correlates the lesion with the activation of a powerful oncogen capable of malignizing this type of cells of the immune system.

https://www.eurekalert.org/pub_releases/2017-03/ibri-ael033017.php

Source: EurekAlert! - Medicine and Health - March 30, 2017 Category: Global & Universal Source Type: news